Mergers and Acquisition Hospital Template: LOI, Diligence, and Closing Playbook (2026)

A mergers and acquisition hospital template is not a generic asset purchase agreement with the word “hospital” pasted into the recitals. Hospital deals carry Certificate of Need approvals, Anti-Kickback Statute exposure, Stark Law physician arrangements, HIPAA business associate transfers, Joint Commission accreditation continuity, and Medicare provider number reassignment, and a deal template that ignores any of those layers will stall at signing or trigger regulatory clawback months after close. According to Kaiser Family Foundation 2025 hospital transaction tracking, 73 hospital deals closed in 2024, with average deal size up 19 percent year over year, and roughly one in four required state attorney general or Federal Trade Commission review before clearing.

What This Actually Means

A hospital M and A template is the package of contract structures, schedules, regulatory filings, and pre-close conditions that move a hospital, health system, ambulatory surgery center, or large physician group from signed letter of intent to closed transaction. Unlike a manufacturer or distributor deal where the asset purchase agreement and a working capital adjustment do most of the heavy lifting, a hospital deal lives or dies on regulatory carve-outs. The Federal Trade Commission and the Department of Justice have actively challenged hospital consolidations since the 2014 ProMedica matter, where the Sixth Circuit upheld divestiture of St. Luke’s Hospital in Ohio. Health Affairs reported in March 2025 that post-merger price increases ran 6 to 18 percent in concentrated markets, which has tightened antitrust scrutiny on every deal above roughly 150 million dollars in combined revenue.

The practical effect is that a hospital deal template has three documents most operators do not encounter in a normal business sale. First, a Hart-Scott-Rodino premerger notification if the transaction crosses the 119.5 million dollar 2025 threshold set by the FTC. Second, a state Certificate of Need application or CON exemption letter, required in 35 states and the District of Columbia as of Kaiser Family Foundation’s 2025 CON tracker. Third, a CMS Form 855A change of ownership filing through PECOS, the Provider Enrollment Chain and Ownership System, which governs whether the Medicare provider number transfers or terminates at close.

The Healthcare Financial Management Association notes that hospital deal templates also require parallel commercial payer contract review. A 200-bed community hospital typically holds 30 to 60 active managed care contracts with Blue Cross, UnitedHealthcare, Aetna, Cigna, Humana Medicare Advantage, and regional Medicaid managed care organizations. Each contract has an assignment clause, a change of control clause, or both, and the deal cannot fund without written payer consent or an opt-out election filed in time to maintain in-network status.

The Eleven Things You Need to Understand

1. Certificate of Need (CON) Approval

Current state: 35 states plus DC require CON approval for a change of ownership at acute care hospitals, per the National Conference of State Legislatures 2025 review. States like Tennessee, North Carolina, Georgia, and New York have active programs with 60 to 270 day review windows. States like California, Texas, and Colorado have repealed or never had CON laws and require only routine licensure transfer.

Target state: A pre-signing CON workbook that maps the target’s licensed bed count, services (cardiac cath lab, obstetrics, oncology, organ transplant), and county service area against the state’s bed-need formula. A CON exemption letter is preferable where the state allows a same-control reorganization, since exemption review runs 30 to 60 days versus full CON which can run 270 days plus appeal.

Impact on outcome: Skipping the CON workbook is the single most common reason hospital deals miss their target close date. A delayed CON adds 90 to 180 days, and during that period the seller continues to absorb operating losses while the buyer’s lenders may reprice or pull the financing commitment.

2. Anti-Kickback Statute (AKS) Exposure

The Anti-Kickback Statute at 42 USC 1320a-7b prohibits any payment intended to induce referrals for items reimbursed by federal healthcare programs. In a hospital deal, AKS shows up in three places: physician compensation arrangements being acquired, joint ventures with referring physicians, and any earnout or contingent payment tied to volume or referrals. The Office of Inspector General has published safe harbors at 42 CFR 1001.952 for personal services, equipment rental, space rental, employment, and bona fide investment interests, and the template must map every acquired physician arrangement to a specific safe harbor or document why no safe harbor is needed.

The 2024 DOJ settlement with a regional health system in the Southeast (announced via HHS-OIG press release, October 2024) resolved AKS allegations tied to physician medical directorships valued above fair market value. The settlement totaled 36.8 million dollars, and the underlying conduct came in through an acquisition where the buyer assumed the medical director contracts without re-pricing them to fair market value at closing.

3. Stark Law Physician Self-Referral

Stark Law at Section 1877 of the Social Security Act prohibits a physician from referring Medicare patients for designated health services to an entity with which the physician has a financial relationship, unless an exception applies. Hospital deals trigger Stark in the medical office building leases the target owns, the physician employment contracts being acquired, the on-call coverage arrangements, and any income guarantees or recruitment agreements still in their commitment period.

The deal template needs a Stark schedule for every physician relationship, identifying the applicable exception (employment, personal services arrangement, fair market value compensation, rural provider, group practice). CMS finalized the value-based exceptions in December 2020 and clarified the writing and signature requirements in subsequent rulemaking, but the buyer still owns the historical compliance risk back to the date the seller entered each arrangement.

4. HIPAA Business Associate Agreement Transfer

HIPAA Privacy Rule at 45 CFR 164.504(e) governs business associate agreements (BAAs), and a hospital typically holds 75 to 200 active BAAs with billing vendors, transcription services, IT contractors, cloud EHR hosts, and law firms. The standard template should not assume BAAs transfer automatically. Many BAAs have an assignment restriction, a notice clause, or a termination right triggered by change of control. The diligence checklist must inventory every BAA, flag termination and assignment provisions, and the closing documents should include a master assignment and consent package covering the BAAs that require it.

The Office for Civil Rights at HHS imposes penalties up to 1.5 million dollars per violation category per year for HIPAA violations, and a buyer that assumes operations without a clean BAA chain inherits the historical exposure. A representations and warranties package on HIPAA compliance, with a specific indemnity carve-out, is standard in hospital deals above 50 million dollars in transaction value.

5. Joint Commission (TJC) Accreditation Transition

The Joint Commission accredits roughly 78 percent of US hospitals according to TJC’s 2025 annual report, and Medicare conditions of participation require either Joint Commission accreditation or state survey equivalence. When a hospital changes ownership, the Joint Commission requires notification within 30 days and a triennial survey may be accelerated. The deal template should include a TJC notification letter, a copy of the current accreditation award, and the most recent triennial survey report with any requirements for improvement.

If the target uses an alternative accreditor such as DNV or the Healthcare Facilities Accreditation Program, the same change of ownership notification rules apply, and the buyer’s compliance team needs to confirm the accreditor’s specific notice timeline. Lapses in accreditation jeopardize Medicare conditions of participation and can trigger payer contract termination clauses, so this is not a back-burner item.

6. Payer Contract Assignment and Notice

Most managed care contracts contain either an assignment clause that requires the payer’s written consent or a change of control clause that gives the payer an early termination right. The deal template needs a payer matrix listing every contract, the assignment language, the notice period, the renegotiation hook, and the current rates. A common buyer mistake is assuming all contracts auto-assign in an asset deal because the buyer is taking the same Medicare provider number through a CHOW. The Medicare provider number transfers, but the commercial contracts often do not.

HFMA’s 2024 managed care benchmarking report noted that hospitals lose 4 to 11 percent of net revenue in the first 12 months post-close when payer transition is mishandled. The recovery costs are significant: re-credentialing across 200 plus physicians, re-loading fee schedules in the payer system, and resubmitting denied claims under the new tax ID.

7. EMR and EHR Integration

If the buyer runs Epic and the target runs Cerner Millennium or Meditech, the integration plan is a six to eighteen month project costing 8 to 25 million dollars for a 200-bed hospital based on KLAS Research 2025 conversion data. The deal template must include a schedule of clinical systems, the current vendor contracts, the renewal dates, the data archive plan for the legacy EHR, and the regulatory data retention obligations (typically 10 years for adult records and to age of majority plus 7 for pediatric records under most state laws).

If the buyer plans to keep two EHRs running, the interoperability and patient matching exposure becomes a clinical safety issue and a quality measure reporting headache. The Joint Commission has cited several health systems for medication reconciliation lapses tied to dual-EHR environments, so the integration timeline is not just an IT line item.

8. Medical Staff Bylaws and Privileging

Medical staff bylaws are a contract between the hospital and the medical staff, and they typically require a vote of the medical executive committee before they can be amended or terminated. A change of ownership does not automatically void the bylaws or the privileges granted under them. The deal template needs a medical staff transition plan that addresses whether existing privileges carry over to the new ownership structure, whether the medical executive committee will continue or be reconstituted, and how peer review files transfer (subject to state peer review privilege protections).

The bylaws often include a fair hearing process, and aggrieved physicians have used post-close bylaws disputes to litigate against new owners. The template should also include a schedule of pending peer review actions, fair hearings in process, and any National Practitioner Data Bank reports filed or pending.

9. Medicare Provider Agreement and PECOS Transfer

The CMS Form 855A change of ownership election determines whether the Medicare provider number and provider agreement transfer to the buyer or terminate at close. In a CHOW, the buyer steps into the seller’s provider agreement, including the historical compliance obligations, the open audits, the recoupment exposure on extrapolated overpayments, and the cost report liabilities. Some buyers prefer a new provider number to break the chain, but a new number means a six to twelve month gap in Medicare billing during the new provider enrollment.

The deal template needs a PECOS schedule showing the current provider agreement, the open RAC (Recovery Audit Contractor) and UPIC (Unified Program Integrity Contractor) reviews, the open cost report years, and any pending Medicare overpayment determinations. A specific indemnity covering pre-close Medicare billing exposure is standard, with an extended survival period since CMS recovery actions can run six years out under the False Claims Act look-back.

10. 340B Drug Pricing Program Eligibility

The 340B program at 42 USC 256b allows certain covered entities (Disproportionate Share Hospitals at or above 11.75 percent DSH adjustment, critical access hospitals, sole community hospitals, rural referral centers, free-standing cancer hospitals, and children’s hospitals) to purchase outpatient drugs at discounts averaging 25 to 50 percent below wholesale acquisition cost, per HRSA 2025 program data. A change of ownership requires recertification with HRSA’s Office of Pharmacy Affairs, and eligibility is re-tested under the new ownership structure.

A common deal-killer is the buyer combining two hospitals where one was DSH-eligible and one was not. The combined entity’s DSH percentage may drop below the 11.75 percent threshold, ending 340B eligibility and removing 8 to 30 million dollars of annual program savings from the pro forma. The deal template needs a 340B eligibility memo from healthcare counsel as part of pre-LOI diligence, not a post-LOI surprise.

11. GME Residency Program Continuity

Teaching hospitals receive Medicare graduate medical education payments through both direct GME and indirect medical education (IME) adjustments. CMS rules on resident caps and per-resident amounts treat a change of ownership as a continuation if the residency programs continue at the same location with the same sponsoring institution. If the buyer plans to consolidate programs, transfer residents, or close programs, ACGME accreditation review and CMS resident cap adjustment both come into play. The deal template needs a GME schedule showing approved resident slots, current fill rate, sponsoring institution agreements with affiliated medical schools, and the most recent ACGME program reviews.

Worked Example: Mid-Sized Community Hospital Deal

Consider a fictional 180-bed not-for-profit community hospital in a CON state, with the following profile drawn from typical HFMA benchmarking data for hospitals in the 150 to 250 bed range:

Assume a regional health system buyer running Epic, with 9 hospitals already and a combined market position that triggers Hart-Scott-Rodino reporting (combined revenue is well above the 119.5 million dollar 2025 threshold). The buyer offers 6.5 times trailing EBITDA, which yields a 143 million dollar enterprise value, plus 18 million dollars of assumed debt and 12 million dollars of working capital, for a deal value of roughly 173 million dollars.

The template must address the following pre-close items in parallel: HSR filing within 30 days of signing (15 day waiting period extendable on second request); CON application in the state’s filing window (typical 90 to 180 day review); CMS Form 855A CHOW with effective date matched to closing; state attorney general notice if the target is a not-for-profit converting or selling significant assets (Massachusetts, California, New York, Illinois, and several other states have notice statutes); HRSA 340B recertification application; Joint Commission change of ownership notification; ACGME notification on the GME programs; payer notice on all 41 contracts with a target of obtaining written consent on the top 10 by revenue; and BAA assignment package covering the 112 BAAs.

Realistic time to close: 9 to 14 months from signed LOI, with the CON review and HSR clearance being the long poles. The buyer’s diligence budget for a deal of this size typically runs 1.8 to 3.2 million dollars across healthcare regulatory counsel, FMV opinions, quality of earnings, IT diligence, and clinical operations review.

Template LOI Structure for Hospital Deals

A hospital letter of intent differs from a generic LOI in several places. Below is a section-by-section template of what should appear.

Hospital Deal Due Diligence Checklist (Healthcare-Only Items)

Standard M and A diligence covers financial, legal, tax, and operational. A hospital deal layers on the following healthcare-specific request list. For the broader process, see our guide on the mergers and acquisitions due diligence process and the breakdown of types of due diligence in mergers and acquisitions.

Common Mistakes in Hospital Deal Templates

Treating CON as a Closing Mechanic Instead of a Pre-LOI Filter

Some buyers sign an LOI and then discover the state’s CON formula prohibits the transaction outright, or the bed-need calculation requires divestiture of services. CON should be analyzed before LOI, with a written memo from regulatory counsel addressing exemption availability, expected review timeline, and likely conditions.

Assuming Medicare Provider Number Transfer is Automatic

The CMS Form 855A CHOW process takes 60 to 180 days, and the effective date is the date of CMS approval, which may be retroactive to closing or may not be, depending on the Medicare Administrative Contractor processing the form. Cash flow modeling that assumes uninterrupted Medicare billing across closing is often wrong.

Underestimating Payer Re-Credentialing Time

If the buyer brings the hospital under a new tax ID, every billing provider has to be re-credentialed by every payer. This can run 90 to 180 days per payer per provider, and during the re-credentialing window claims may be denied or held. The deal template should include a payer transition plan with specific milestones and a cash reserve for the working capital impact.

Ignoring the Medical Staff as a Stakeholder

Medical staff bylaws are a contract, and aggrieved physicians can litigate. A deal that surprises the medical staff with a closing announcement risks both retention losses and bylaws-based litigation. The template should include a medical staff communication plan, ideally a meet-and-greet with key service line chiefs before signing, structured as a clean-team or attorney-privileged discussion.

Treating BAAs as Boilerplate

BAAs vary widely. Some assign by operation of law, some require written consent, some terminate on change of control, and a few impose data return or destruction obligations on termination. Pulling 100 plus BAAs into a single master assignment without reading each one is a frequent cause of post-close OCR exposure.

Not Pricing the 340B Eligibility Risk

If the combined entity loses 340B eligibility, the buyer loses 8 to 30 million dollars a year in program savings on a mid-sized hospital. That should be either a closing condition or a price adjustment, not a post-close surprise.

Timeline: Signed LOI to Closing

1. Days 1 to 30: HSR filing prepared and submitted. State attorney general notice letter delivered. State licensure transfer application initiated. Joint Commission change of ownership notification sent. ACGME notification sent. CON application drafted.
2. Days 30 to 75: HSR 15 day waiting period expires (or second request issued, restarting clock). Buyer diligence runs in parallel: regulatory, financial, IT, clinical operations, real estate, environmental. CON application filed in state’s filing window. CMS Form 855A CHOW filed.
3. Days 75 to 150: CON public hearing (where required). Payer outreach for assignment consent on top contracts. BAA assignment package drafted. Quality of earnings completed. Working capital target finalized. Definitive Asset Purchase Agreement negotiation.
4. Days 150 to 240: Definitive agreement signed. CON approval received (where required). State attorney general approval received (for not-for-profit conversions). HRSA 340B recertification filed. ACGME program continuation approval received. Payer consents collected. Final BAA assignments.
5. Days 240 to 365: Final regulatory approvals. CMS CHOW effective date set. Closing prep: closing checklist, funds flow, disclosure schedules updated, bring-down certificates. Day of close: filings effective, funds wired, Medicare provider number effective for buyer.
6. Days 365 to 540: Post-close integration: EHR transition, payer re-credentialing, financial system integration, medical staff dues collection transition, quality program integration, GME program continuation under new sponsoring institution structure if applicable.

Frequently Asked Questions

Do all hospital deals need Hart-Scott-Rodino filings?

No. HSR is required only when the size-of-transaction test (119.5 million dollars in 2025) and the size-of-person test (one party at 23.9 million dollars in assets/sales and another at 239 million dollars, in 2025) are both met. Smaller deals or deals involving only nonprofit entities with no commerce nexus may be exempt, but the analysis is fact-specific and should be confirmed by antitrust counsel.

Can a buyer get a new Medicare provider number instead of taking the seller’s?

Yes. The buyer can elect not to assume the seller’s provider agreement and instead enroll as a new provider. This breaks the chain of historical liability but creates a billing gap of typically 90 to 180 days while CMS processes the new enrollment. Most buyers take the CHOW to avoid the gap and negotiate specific indemnity for pre-close Medicare exposure.

How long does Joint Commission re-survey take after a change of ownership?

The Joint Commission requires notification within 30 days of close. TJC may accelerate the next triennial survey or conduct a focused survey, depending on the scope of operational changes. There is no automatic re-survey trigger, but a substantial change in services or licensed beds typically prompts focused review.

What happens to physician employment contracts at close?

If the deal is structured as a stock or membership purchase, contracts continue without assignment. In an asset deal, each employment contract has to be assigned (with consent if required) or terminated and re-issued by the buyer. Most buyers re-issue with fresh fair market value documentation to reset the Stark Law compliance clock.

How is the 340B program affected by a hospital merger?

HRSA requires recertification at change of ownership. Eligibility is re-tested under the new entity structure. If the combined entity does not meet the DSH adjustment percentage threshold or other eligibility criteria, 340B participation ends. Hospitals should obtain a 340B eligibility memo from healthcare counsel as part of pre-LOI diligence.

Do hospital deals always require state attorney general approval?

No, but many do. About 20 states have notice or approval statutes when a nonprofit hospital sells, converts, or transfers significant assets. California, Massachusetts, New York, Illinois, Washington, and Oregon are among the most active. The review focuses on charitable assets, community benefit, and whether sale proceeds are dedicated to a successor charity.

What to Do Next

A hospital deal template is not a download. It is a coordinated set of contract structures, regulatory filings, and pre-close operating commitments that vary by state, by payer mix, by accreditor, by GME footprint, and by the buyer’s existing market position. The buyers who close on time treat the regulatory layer as a parallel workstream from LOI signing, not a closing-week scramble.

If you operate a hospital, a health system, an ambulatory surgery center, or a large physician group and are evaluating a sale, CT Acquisitions runs the buyer process so the seller pays no advisory fees. Buyers pay us, not you. We coordinate the CON workbook, payer matrix, BAA inventory, and 340B eligibility memo alongside your counsel so the deal closes on the original timeline.